572 related articles for article (PubMed ID: 15988529)
1. Global histone modification patterns predict risk of prostate cancer recurrence.
Seligson DB; Horvath S; Shi T; Yu H; Tze S; Grunstein M; Kurdistani SK
Nature; 2005 Jun; 435(7046):1262-6. PubMed ID: 15988529
[TBL] [Abstract][Full Text] [Related]
2. Global levels of histone modifications predict prostate cancer recurrence.
Ellinger J; Kahl P; von der Gathen J; Rogenhofer S; Heukamp LC; Gütgemann I; Walter B; Hofstädter F; Büttner R; Müller SC; Bastian PJ; von Ruecker A
Prostate; 2010 Jan; 70(1):61-9. PubMed ID: 19739128
[TBL] [Abstract][Full Text] [Related]
3. Cancer: a changing global view.
Marte B
Nature; 2005 Jun; 435(7046):1172. PubMed ID: 15988507
[No Abstract] [Full Text] [Related]
4. Association of global levels of histone modifications with recurrence-free survival in stage IIB and III esophageal squamous cell carcinomas.
I H; Ko E; Kim Y; Cho EY; Han J; Park J; Kim K; Kim DH; Shim YM
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):566-73. PubMed ID: 20142251
[TBL] [Abstract][Full Text] [Related]
5. Global histone modifications predict prognosis of resected non small-cell lung cancer.
Barlési F; Giaccone G; Gallegos-Ruiz MI; Loundou A; Span SW; Lefesvre P; Kruyt FA; Rodriguez JA
J Clin Oncol; 2007 Oct; 25(28):4358-64. PubMed ID: 17906200
[TBL] [Abstract][Full Text] [Related]
6. The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma.
Park YS; Jin MY; Kim YJ; Yook JH; Kim BS; Jang SJ
Ann Surg Oncol; 2008 Jul; 15(7):1968-76. PubMed ID: 18470569
[TBL] [Abstract][Full Text] [Related]
7. Global histone H3K27 methylation levels are different in localized and metastatic prostate cancer.
Ellinger J; Kahl P; von der Gathen J; Heukamp LC; Gütgemann I; Walter B; Hofstädter F; Bastian PJ; von Ruecker A; Müller SC; Rogenhofer S
Cancer Invest; 2012 Feb; 30(2):92-7. PubMed ID: 22149091
[TBL] [Abstract][Full Text] [Related]
8. The global histone modification pattern correlates with overall survival in metachronous liver metastasis of colorectal cancer.
Tamagawa H; Oshima T; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Masuda M; Imada T; Miyagi Y
Oncol Rep; 2012 Mar; 27(3):637-42. PubMed ID: 22076537
[TBL] [Abstract][Full Text] [Related]
9. Histone methylation at gene promoters is associated with developmental regulation and region-specific expression of ionotropic and metabotropic glutamate receptors in human brain.
Stadler F; Kolb G; Rubusch L; Baker SP; Jones EG; Akbarian S
J Neurochem; 2005 Jul; 94(2):324-36. PubMed ID: 15998284
[TBL] [Abstract][Full Text] [Related]
10. Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients.
Song JS; Kim YS; Kim DK; Park SI; Jang SJ
Pathol Int; 2012 Mar; 62(3):182-90. PubMed ID: 22360506
[TBL] [Abstract][Full Text] [Related]
11. Abnormal histone modification patterns in lupus CD4+ T cells.
Hu N; Qiu X; Luo Y; Yuan J; Li Y; Lei W; Zhang G; Zhou Y; Su Y; Lu Q
J Rheumatol; 2008 May; 35(5):804-10. PubMed ID: 18398941
[TBL] [Abstract][Full Text] [Related]
12. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
13. A decade of histone acetylation: marking eukaryotic chromosomes with specific codes.
Kimura A; Matsubara K; Horikoshi M
J Biochem; 2005 Dec; 138(6):647-62. PubMed ID: 16428293
[TBL] [Abstract][Full Text] [Related]
14. SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells.
Cuomo A; Moretti S; Minucci S; Bonaldi T
Amino Acids; 2011 Jul; 41(2):387-99. PubMed ID: 20617350
[TBL] [Abstract][Full Text] [Related]
15. Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis.
Cottrell S; Jung K; Kristiansen G; Eltze E; Semjonow A; Ittmann M; Hartmann A; Stamey T; Haefliger C; Weiss G
J Urol; 2007 May; 177(5):1753-8. PubMed ID: 17437806
[TBL] [Abstract][Full Text] [Related]
16. Zinc-alpha2-glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomy.
Henshall SM; Horvath LG; Quinn DI; Eggleton SA; Grygiel JJ; Stricker PD; Biankin AV; Kench JG; Sutherland RL
J Natl Cancer Inst; 2006 Oct; 98(19):1420-4. PubMed ID: 17018789
[TBL] [Abstract][Full Text] [Related]
17. Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence.
Seligson DB; Hongo F; Huerta-Yepez S; Mizutani Y; Miki T; Yu H; Horvath S; Chia D; Goodglick L; Bonavida B
Clin Cancer Res; 2007 Oct; 13(20):6056-63. PubMed ID: 17947468
[TBL] [Abstract][Full Text] [Related]
18. Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development.
Bianco-Miotto T; Chiam K; Buchanan G; Jindal S; Day TK; Thomas M; Pickering MA; O'Loughlin MA; Ryan NK; Raymond WA; Horvath LG; Kench JG; Stricker PD; Marshall VR; Sutherland RL; Henshall SM; Gerald WL; Scher HI; Risbridger GP; Clements JA; Butler LM; Tilley WD; Horsfall DJ; Ricciardelli C;
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2611-22. PubMed ID: 20841388
[TBL] [Abstract][Full Text] [Related]
19. Post-translational modifications of Trypanosoma cruzi histone H4.
da Cunha JP; Nakayasu ES; de Almeida IC; Schenkman S
Mol Biochem Parasitol; 2006 Dec; 150(2):268-77. PubMed ID: 17010453
[TBL] [Abstract][Full Text] [Related]
20. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition.
Garcia BA; Busby SA; Shabanowitz J; Hunt DF; Mishra N
J Proteome Res; 2005; 4(6):2032-42. PubMed ID: 16335948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
